Shire plc/ JE00B2QKY057 /
2019-03-04 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
63.0000USD | - | 250 Turnover: - |
-Bid Size: - | -Ask Size: - | 63.0000 | 63.0000 |
GlobeNewswire
04-25
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...
GlobeNewswire
03-25
Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Assoc...
GlobeNewswire
03-19
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing ...
GlobeNewswire
03-07
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OL...
GlobeNewswire
02-14
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming Nation...
GlobeNewswire
02-02
Brooklyn Law School Announces Allen Grubman Chair in Media and Entertainment Law
GlobeNewswire
01-30
Tome Biosciences Appoints Industry Veteran Daniel Curran, MD, to its Board of Directors
GlobeNewswire
01-23
Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming Mi...
GlobeNewswire
01-22
Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Busines...
GlobeNewswire
01-16
Paratek Pharmaceuticals Announces Promotion of Jonathan Light to General Counsel, Corporate Secretar...
GlobeNewswire
01-07
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical ...
GlobeNewswire
2023-12-18
Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylantha...
GlobeNewswire
2023-11-14
Unicycive Announces Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-11-14
Outlook Therapeutics® Adds Global Commercial Expertise with Appointment of Jedd Comiskey as Senior V...
GlobeNewswire
2023-11-07
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results